Interpharma: financing health from the perspective of Health2020

Before Interpharma, the association of research-based pharmaceutical companies, Alain Berset recalls the industry’s first public appearance: a 25-metre tower at the 1939 Landi.

On substance: “Gesundheitspolitik bedeutet also nicht einfach Kosten senken.” But costs will keep rising: according to the Federal Finance Administration, they will go from 11% of GDP today to almost 16% in 2060.

Speeches on this site

• Interpharma : le financement de la santé dans la perspective de Santé2020 (in German, French-language page)